Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation

Acquired genetic and epigenetic alterations in normal cells give rise to transformed cells, which lead to tumor development. Elucidation of the precise mechanisms underlying primary and metastatic tumor formation is required. MicroRNAs (miRNAs) are small noncoding RNAs that play a major role in post...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cancer 2016-03, Vol.138 (6), p.1337-1349
Hauptverfasser: Ishimoto, Takatsugu, Baba, Hideo, Izumi, Daisuke, Sugihara, Hidetaka, Kurashige, Junji, Iwatsuki, Masaaki, Tan, Patrick
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1349
container_issue 6
container_start_page 1337
container_title International journal of cancer
container_volume 138
creator Ishimoto, Takatsugu
Baba, Hideo
Izumi, Daisuke
Sugihara, Hidetaka
Kurashige, Junji
Iwatsuki, Masaaki
Tan, Patrick
description Acquired genetic and epigenetic alterations in normal cells give rise to transformed cells, which lead to tumor development. Elucidation of the precise mechanisms underlying primary and metastatic tumor formation is required. MicroRNAs (miRNAs) are small noncoding RNAs that play a major role in post‐transcriptional gene regulation during various biological processes. Accumulating evidence suggests that dysregulation of miRNAs is intimately involved in the carcinogenesis, progression and metastasis of many cancers, including gastric cancers (GCs), while the alteration of certain miRNAs provides biomarkers to detect early GCs. This review summarizes the most recent findings into the mechanisms of miRNA‐mediated regulation of GCs, which will support the development of diagnostic biomarkers and novel therapeutic strategies.
doi_str_mv 10.1002/ijc.29627
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_1755925299</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3918776141</sourcerecordid><originalsourceid>FETCH-LOGICAL-j4507-e17ee65acfa6bdd8610bf0d1de84b567a13a6cfb754d50131d2b86134f132bea3</originalsourceid><addsrcrecordid>eNo9kF1LwzAUhoMobk4v_AMS8LpbkjbNejmGH5OhIHod0uR0pnZtTVpH_71xm16dA-_zngMPQteUTCkhbGZLPWVZysQJGlOSiYgwyk_ROGQkEjROR-jC-5IQSjlJztGIpSQJIBujYtk7B3WHW3C-Bd3Zb_C4a3bKGdx9ALYmpLawWnW2qXFT4E8YcFupIRSwrfFG-c5ZjbWqNTi8tdo1r88LbAbvYNNX-94lOitU5eHqOCfo_f7ubfkYrV8eVsvFOioTTkQEVACkXOlCpbkx85SSvCCGGpgnOU-ForFKdZELnhhOaEwNywMUJwWNWQ4qnqDbw93WNV89-E6WTe_q8FJSwXnGOMuyQN0cqT7fgpGts1vlBvmnJQCzA7CzFQz_OSXy17cMvuXet1w9LfdL_AN7Z3Oz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1755925299</pqid></control><display><type>article</type><title>Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Ishimoto, Takatsugu ; Baba, Hideo ; Izumi, Daisuke ; Sugihara, Hidetaka ; Kurashige, Junji ; Iwatsuki, Masaaki ; Tan, Patrick</creator><creatorcontrib>Ishimoto, Takatsugu ; Baba, Hideo ; Izumi, Daisuke ; Sugihara, Hidetaka ; Kurashige, Junji ; Iwatsuki, Masaaki ; Tan, Patrick</creatorcontrib><description>Acquired genetic and epigenetic alterations in normal cells give rise to transformed cells, which lead to tumor development. Elucidation of the precise mechanisms underlying primary and metastatic tumor formation is required. MicroRNAs (miRNAs) are small noncoding RNAs that play a major role in post‐transcriptional gene regulation during various biological processes. Accumulating evidence suggests that dysregulation of miRNAs is intimately involved in the carcinogenesis, progression and metastasis of many cancers, including gastric cancers (GCs), while the alteration of certain miRNAs provides biomarkers to detect early GCs. This review summarizes the most recent findings into the mechanisms of miRNA‐mediated regulation of GCs, which will support the development of diagnostic biomarkers and novel therapeutic strategies.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.29627</identifier><identifier>PMID: 26041092</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Animals ; Biomarkers ; Biomarkers, Tumor ; Cancer ; cancer biomarker ; Cell Movement - genetics ; Cell Transformation, Neoplastic - genetics ; Disease Progression ; Drug Resistance, Neoplasm - drug effects ; gastric cancer ; Gene Expression Regulation, Neoplastic ; H. pylori ; Host-Pathogen Interactions - genetics ; Humans ; Medical research ; microRNA ; MicroRNAs - blood ; MicroRNAs - genetics ; Neoplasm Invasiveness ; Neoplasm Metastasis ; Neovascularization, Pathologic - genetics ; Prognosis ; Stomach Neoplasms - diagnosis ; Stomach Neoplasms - drug therapy ; Stomach Neoplasms - genetics ; Stomach Neoplasms - microbiology ; Stomach Neoplasms - mortality ; therapeutic target</subject><ispartof>International journal of cancer, 2016-03, Vol.138 (6), p.1337-1349</ispartof><rights>2015 UICC</rights><rights>2015 UICC.</rights><rights>2016 UICC</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fijc.29627$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fijc.29627$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26041092$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ishimoto, Takatsugu</creatorcontrib><creatorcontrib>Baba, Hideo</creatorcontrib><creatorcontrib>Izumi, Daisuke</creatorcontrib><creatorcontrib>Sugihara, Hidetaka</creatorcontrib><creatorcontrib>Kurashige, Junji</creatorcontrib><creatorcontrib>Iwatsuki, Masaaki</creatorcontrib><creatorcontrib>Tan, Patrick</creatorcontrib><title>Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Acquired genetic and epigenetic alterations in normal cells give rise to transformed cells, which lead to tumor development. Elucidation of the precise mechanisms underlying primary and metastatic tumor formation is required. MicroRNAs (miRNAs) are small noncoding RNAs that play a major role in post‐transcriptional gene regulation during various biological processes. Accumulating evidence suggests that dysregulation of miRNAs is intimately involved in the carcinogenesis, progression and metastasis of many cancers, including gastric cancers (GCs), while the alteration of certain miRNAs provides biomarkers to detect early GCs. This review summarizes the most recent findings into the mechanisms of miRNA‐mediated regulation of GCs, which will support the development of diagnostic biomarkers and novel therapeutic strategies.</description><subject>Animals</subject><subject>Biomarkers</subject><subject>Biomarkers, Tumor</subject><subject>Cancer</subject><subject>cancer biomarker</subject><subject>Cell Movement - genetics</subject><subject>Cell Transformation, Neoplastic - genetics</subject><subject>Disease Progression</subject><subject>Drug Resistance, Neoplasm - drug effects</subject><subject>gastric cancer</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>H. pylori</subject><subject>Host-Pathogen Interactions - genetics</subject><subject>Humans</subject><subject>Medical research</subject><subject>microRNA</subject><subject>MicroRNAs - blood</subject><subject>MicroRNAs - genetics</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Metastasis</subject><subject>Neovascularization, Pathologic - genetics</subject><subject>Prognosis</subject><subject>Stomach Neoplasms - diagnosis</subject><subject>Stomach Neoplasms - drug therapy</subject><subject>Stomach Neoplasms - genetics</subject><subject>Stomach Neoplasms - microbiology</subject><subject>Stomach Neoplasms - mortality</subject><subject>therapeutic target</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kF1LwzAUhoMobk4v_AMS8LpbkjbNejmGH5OhIHod0uR0pnZtTVpH_71xm16dA-_zngMPQteUTCkhbGZLPWVZysQJGlOSiYgwyk_ROGQkEjROR-jC-5IQSjlJztGIpSQJIBujYtk7B3WHW3C-Bd3Zb_C4a3bKGdx9ALYmpLawWnW2qXFT4E8YcFupIRSwrfFG-c5ZjbWqNTi8tdo1r88LbAbvYNNX-94lOitU5eHqOCfo_f7ubfkYrV8eVsvFOioTTkQEVACkXOlCpbkx85SSvCCGGpgnOU-ForFKdZELnhhOaEwNywMUJwWNWQ4qnqDbw93WNV89-E6WTe_q8FJSwXnGOMuyQN0cqT7fgpGts1vlBvmnJQCzA7CzFQz_OSXy17cMvuXet1w9LfdL_AN7Z3Oz</recordid><startdate>20160315</startdate><enddate>20160315</enddate><creator>Ishimoto, Takatsugu</creator><creator>Baba, Hideo</creator><creator>Izumi, Daisuke</creator><creator>Sugihara, Hidetaka</creator><creator>Kurashige, Junji</creator><creator>Iwatsuki, Masaaki</creator><creator>Tan, Patrick</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope></search><sort><creationdate>20160315</creationdate><title>Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation</title><author>Ishimoto, Takatsugu ; Baba, Hideo ; Izumi, Daisuke ; Sugihara, Hidetaka ; Kurashige, Junji ; Iwatsuki, Masaaki ; Tan, Patrick</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j4507-e17ee65acfa6bdd8610bf0d1de84b567a13a6cfb754d50131d2b86134f132bea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Biomarkers</topic><topic>Biomarkers, Tumor</topic><topic>Cancer</topic><topic>cancer biomarker</topic><topic>Cell Movement - genetics</topic><topic>Cell Transformation, Neoplastic - genetics</topic><topic>Disease Progression</topic><topic>Drug Resistance, Neoplasm - drug effects</topic><topic>gastric cancer</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>H. pylori</topic><topic>Host-Pathogen Interactions - genetics</topic><topic>Humans</topic><topic>Medical research</topic><topic>microRNA</topic><topic>MicroRNAs - blood</topic><topic>MicroRNAs - genetics</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Metastasis</topic><topic>Neovascularization, Pathologic - genetics</topic><topic>Prognosis</topic><topic>Stomach Neoplasms - diagnosis</topic><topic>Stomach Neoplasms - drug therapy</topic><topic>Stomach Neoplasms - genetics</topic><topic>Stomach Neoplasms - microbiology</topic><topic>Stomach Neoplasms - mortality</topic><topic>therapeutic target</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ishimoto, Takatsugu</creatorcontrib><creatorcontrib>Baba, Hideo</creatorcontrib><creatorcontrib>Izumi, Daisuke</creatorcontrib><creatorcontrib>Sugihara, Hidetaka</creatorcontrib><creatorcontrib>Kurashige, Junji</creatorcontrib><creatorcontrib>Iwatsuki, Masaaki</creatorcontrib><creatorcontrib>Tan, Patrick</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ishimoto, Takatsugu</au><au>Baba, Hideo</au><au>Izumi, Daisuke</au><au>Sugihara, Hidetaka</au><au>Kurashige, Junji</au><au>Iwatsuki, Masaaki</au><au>Tan, Patrick</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>2016-03-15</date><risdate>2016</risdate><volume>138</volume><issue>6</issue><spage>1337</spage><epage>1349</epage><pages>1337-1349</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><abstract>Acquired genetic and epigenetic alterations in normal cells give rise to transformed cells, which lead to tumor development. Elucidation of the precise mechanisms underlying primary and metastatic tumor formation is required. MicroRNAs (miRNAs) are small noncoding RNAs that play a major role in post‐transcriptional gene regulation during various biological processes. Accumulating evidence suggests that dysregulation of miRNAs is intimately involved in the carcinogenesis, progression and metastasis of many cancers, including gastric cancers (GCs), while the alteration of certain miRNAs provides biomarkers to detect early GCs. This review summarizes the most recent findings into the mechanisms of miRNA‐mediated regulation of GCs, which will support the development of diagnostic biomarkers and novel therapeutic strategies.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>26041092</pmid><doi>10.1002/ijc.29627</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0020-7136
ispartof International journal of cancer, 2016-03, Vol.138 (6), p.1337-1349
issn 0020-7136
1097-0215
language eng
recordid cdi_proquest_journals_1755925299
source MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals
subjects Animals
Biomarkers
Biomarkers, Tumor
Cancer
cancer biomarker
Cell Movement - genetics
Cell Transformation, Neoplastic - genetics
Disease Progression
Drug Resistance, Neoplasm - drug effects
gastric cancer
Gene Expression Regulation, Neoplastic
H. pylori
Host-Pathogen Interactions - genetics
Humans
Medical research
microRNA
MicroRNAs - blood
MicroRNAs - genetics
Neoplasm Invasiveness
Neoplasm Metastasis
Neovascularization, Pathologic - genetics
Prognosis
Stomach Neoplasms - diagnosis
Stomach Neoplasms - drug therapy
Stomach Neoplasms - genetics
Stomach Neoplasms - microbiology
Stomach Neoplasms - mortality
therapeutic target
title Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T00%3A31%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20perspectives%20toward%20the%20identification%20of%20key%20players%20in%20gastric%20cancer%20microRNA%20dysregulation&rft.jtitle=International%20journal%20of%20cancer&rft.au=Ishimoto,%20Takatsugu&rft.date=2016-03-15&rft.volume=138&rft.issue=6&rft.spage=1337&rft.epage=1349&rft.pages=1337-1349&rft.issn=0020-7136&rft.eissn=1097-0215&rft_id=info:doi/10.1002/ijc.29627&rft_dat=%3Cproquest_pubme%3E3918776141%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1755925299&rft_id=info:pmid/26041092&rfr_iscdi=true